Category: Artificial Intelligence

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

Debating Physician Consent Rates in Pharma Transparency

Physician consent can be a contentious issue. Especially when data privacy interpretation comes into play. In a webinar we hosted, Brian Sharkey, VP of Porzio Life Sciences LLC, raised a question about the validity of consent rates as an indicator of pharmaceutical transparency. So, is there a direct correlation between transparency in the pharmaceutical sector […]

Shifting Attitudes Toward Pharma Spend Disclosure

How stringent are pharmaceutical disclosure requirements in your country? Depends on who you’re asking. Team qordata invited Brian Sharkey, Vice President of Porzio Life Sciences LLC, to host our webinar on “EFPIA Reporting and Consent Management”. What he had to say pretty much confirms that when it comes to compliance disclosure, context is key. Some […]

Pharma Compliance Workflow: 2 Phases | Reporting & Analysis

In qordata’s most recent post: A Quick Quiz To Check Your Compliance Analytics Acumen, Zafar Ahmed quotes Ishita Arora on realistic scope assumptions to make when designing one’s compliance/transparency program. We take that discussion a little further today by discussing how to better organize the pharma compliance workflow by dividing it in two phases: Reporting […]

Here’s A Quick Quiz To Check Your Compliance Analytics Acumen

Still unsure about introducing a compliance analytics program into your company? You’re not alone. Of the 9272* medical drug and device companies in the USA, only 1,481 submitted their CMS report in 2016, down from 1,579 in 2015. While for some, macro issues like M&A and CIAs may explain the lack of a report, other […]

Leveraging Data Visibility To Steer Compliance In The Right Direction

Imagine yourself focusing hard, while being mindful of a lot of things simultaneously taking place in many different directions. Lots of sensory and background information flowing at you, which could overwhelm you had you been a newcomer. The task looks operational, but it has high-risk, long-term consequences. It is absolutely necessary to get it right […]

Surprising Figures From CMS Open Payments Data 2016

Pharmaceutical companies do not want to keep doctors away. But even if they did, it would be easier (and riskier) than taking an apple a day. A lot riskier. Tiny typos can have huge consequences. Without meaning to, and often under pressure to meet submission deadlines, compliance/transparency professionals can make errors that increase their workload […]